English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Neuropsychiatric disorders represent a serious medical and human issue. In general, these diseases are detrimental to the quality of life and sociability of afflicted patients. Moreover, they are an immense socio-economic burden. Brain disorders are sometimes denoted as graveyards of pharmaceutical enterprises , referring to relatively a large proportion of drugs for these diseases failing to prove efficient or safe in later phases of clinical trials. Our understanding of what really happens in the central nervous system (CNS) is very limited, especially in relation to normal and pathological behaviors. This limitation also effects the research of neuropsychiatric disorders. We do not know the exact pathogenic mechanisms of numerous diseases, such as Alzheimer's disease or schizophrenia, which prevents the causal treatment of many of them. The symptomatic-like treatment often yields an insufficient therapeutic outcome and in many cases, is accompanied by serious side-effects (as is the case for classical antipsychotics in refractory schizophrenic patients). In some areas of neuro-science research, we are often just beginning to understand brain-behavior relationships in health and disease.

Behavioral Tests for Evaluation of Information Processing and Cognitive Deficits in Rodent Animal Models of Neuropsychiatric Disorders